Patents by Inventor Jonathan K. Armstrong

Jonathan K. Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9919074
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homo-polymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: March 20, 2018
    Assignee: SYNCERA, INC.
    Inventors: Tadeusz Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Patent number: 9616150
    Abstract: A method for controlling bleeding from bones, comprising the use of copolymers of oxyethylene and oxypropylene or mixtures thereof to cover the bleeding portions of bones. The copolymers are resorbable by the body, not metabolized, simple to prepare, inexpensive, readily available, and do not interfere with the fusion, osteogenesis, and related tissue healing and repair of the affected bones.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: April 11, 2017
    Assignee: CHILDREN'S HOSPITAL LOS ANGELES
    Inventors: Michael Levy, Michael Y. Wang, Jonathan K. Armstrong, Timothy C. Fisher
  • Patent number: 8455000
    Abstract: We describe the medical, dental, and surgical uses of modified poly(alkylene) materials which are fully resorbable after implantation into the body, and compositions formulated with such modified poly(alkylene) materials.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: June 4, 2013
    Assignee: Syncera Inc.
    Inventors: Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge, Tadeusz Z. Wellisz
  • Publication number: 20120219497
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homo-polymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Application
    Filed: February 27, 2012
    Publication date: August 30, 2012
    Applicant: SYNCERA, INC.
    Inventors: Tadeusz WELLISZ, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Patent number: 8124687
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homopolymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: February 28, 2012
    Assignee: Syncera, Inc.
    Inventors: Tadeusz Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Publication number: 20110002915
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homopolymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Application
    Filed: September 15, 2010
    Publication date: January 6, 2011
    Applicant: SYNCERA, INC
    Inventors: Tadeusz Z. Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Publication number: 20110002974
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homopolymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Application
    Filed: September 15, 2010
    Publication date: January 6, 2011
    Applicant: SYNCERA, INC.
    Inventors: Tadeusz Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Patent number: 7829616
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homopolymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: November 9, 2010
    Assignee: Syncera, Inc.
    Inventors: Tadeusz Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Publication number: 20090286886
    Abstract: We describe the medical, dental, and surgical uses of modified poly(alkylene) materials which are fully resorbable after implantation into the body, and compositions formulated with such modified poly(alkylene) materials.
    Type: Application
    Filed: May 22, 2007
    Publication date: November 19, 2009
    Inventors: Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge, Tadeusz Z. Wellisz
  • Publication number: 20090238758
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homopolymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Application
    Filed: June 8, 2009
    Publication date: September 24, 2009
    Applicant: SYNCERA, INC.
    Inventors: Tadeusz WELLISZ, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Publication number: 20090191175
    Abstract: The present invention discloses methods and devices for selectively removing anti-PEG antibodies from a patient's blood prior to administration of a PEG-conjugated therapeutic agent so as to prevent immune reactions against the PEG-conjugated therapeutic agents when the agents are administered as a therapeutic regimen. Removal of anti-PEG antibodies may be physical, in which anti-PEG antibodies are physically removed from the blood through an extracorporeal blood circuit connected to an anti-PEG antibody removal device, or functional, in which an anti-PEG inactivating agent is infused into the patient's blood stream prior to administration of the PEG-conjugated therapeutic agent. Also disclosed is a device for selectively removing anti-PEG antibodies from a blood stream and system incorporating the device.
    Type: Application
    Filed: February 20, 2009
    Publication date: July 30, 2009
    Applicant: University of Southern California
    Inventors: Jonathan K. ARMSTRONG, Timothy C. Fisher
  • Patent number: 7553913
    Abstract: A polymeric material comprised of (i) at least one random copolymer comprised of ethylene oxide and one or more other alkylene oxide(s) and (ii) at least one non-random polymer comprised of one or more poly(alkylene oxide)s has been discovered. Preferably, it is a polymer alloy. Alkylene oxide homo-polymers or block copolymers may be the non-random polymer. In a related discovery, an adhesive material can be made by suspending (a) particles in (b) a matrix of at least one poly(ethylene oxide) copolymer of ethylene oxide and propylene oxide, or a combination thereof. The handling characteristics may be adjusted for different utilities (e.g., from runny oil to hard wax). Applications include use as adhesive, cohesive, filler, lubricant, surfactant, or any combination thereof. In particular, the hard materials may be used for cleaning or waxing.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: June 30, 2009
    Assignee: Syncera, Inc.
    Inventors: Tadeusz Wellisz, Timothy C. Fisher, Jonathan K. Armstrong, John Cambridge
  • Publication number: 20080145876
    Abstract: The present invention discloses an assay for determining the presence of an anti-PEG antibody in a biological sample. Embodiments according to this aspect of the present invention will generally have the steps of: (1) providing an antigen probe capable of forming an antibody-antigen complex with the anti-PEG antibody; (2) contacting the biological sample with the antigen probe under conditions favorable for formation of the antibody-antigen complex; and (3) analyzing the antigen probe, after having performed step (2), to detect for the presence of the antibody-antigen complex, wherein the presence of the anti-PEG antibody is determined if the antibody-antigen complex is detected. Also disclosed are methods for screening patients, methods for monitoring patients using assays of this invention and kits for performing thereof.
    Type: Application
    Filed: November 20, 2007
    Publication date: June 19, 2008
    Applicant: University of Southern California
    Inventors: Jonathan K. Armstrong, Timothy C. Fisher
  • Patent number: 7174676
    Abstract: A device mountable to a gutter for removing debris therefrom includes an elongated shaft with proximal and distal end portions positionable within the gutter, a plurality of debris-removing members mounted about the shaft and between the proximal and distal end portions thereof, a plurality of brackets spaced along the gutter for receiving the shaft therethrough, and a mechanism for operating the device causing the debris-removing members to rotate in a select direction as desired by a user. The operating mechanism may rotate the debris-removing members in an oscillating path or unidirectional path and a sensor may also be included to selectively toggle the device between on and off modes, without direct user input.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: February 13, 2007
    Inventor: Jonathan K. Armstrong
  • Patent number: 6942859
    Abstract: Living cells modified at their surface with specially selected polymers are disclosed. A simple method to covalently attach specially selected PEG derivatives to the surface of RBC in aqueous media under mild conditions is a preferred example. The selected PEG-modification dramatically reduced aggregation and low shear viscosity of RBC resuspended in autologous plasma, and inhibited RBC agglutination by blood group-specific antibodies. The morphology and deformability of the PEG-treated cells were unaltered. The PEG coating of the RBC surface is applicable to the treatment of a variety of diseases characterized by vaso-occlusion or impaired blood flow, e.g., myocardial infarction, shock, and sickle cell disease.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: September 13, 2005
    Assignee: University of Southern California
    Inventors: Timothy C. Fisher, Jonathan K. Armstrong
  • Publication number: 20030095945
    Abstract: A method for controlling bleeding from bones, comprising the use of copolymers of oxyethylene and oxypropylene or mixtures thereof to cover the bleeding portions of bones. The copolymers are resorbable by the body, not metabolized, simple to prepare, inexpensive, readily available, and do not interfere with the fusion, osteogenesis, and related tissue healing and repair of the affected bones.
    Type: Application
    Filed: April 29, 2002
    Publication date: May 22, 2003
    Applicant: Children's Hospital Los Angeles
    Inventors: Michael Levy, Michael Y. Wang, Jonathan K. Armstrong, Timothy C. Fisher
  • Publication number: 20020141976
    Abstract: Living cells modified at their surface with specially selected polymers are disclosed. A simple method to covalently attach specially selected PEG derivatives to the surface of RBC in aqueous media under mild conditions is a preferred example. The selected PEG-modification dramatically reduced aggregation and low shear viscosity of RBC resuspended in autologous plasma, and inhibited RBC agglutination by blood group-specific antibodies. The morphology and deformability of the PEG-treated cells were unaltered. The PEG coating of the RBC surface is applicable to the treatment of a variety of diseases characterized by vaso-occlusion or impaired blood flow, e.g., myocardial infarction, shock, and sickle cell disease.
    Type: Application
    Filed: November 5, 2001
    Publication date: October 3, 2002
    Applicant: The University of Southern Clifornia
    Inventors: Timothy C. Fisher, Jonathan K. Armstrong
  • Patent number: 6312685
    Abstract: Living cells are modified at their surface with specially selected polymers. Covalently attaching specially selected polyethylene glycol (PEG) derivatives to the surface of red blood cells (RBC) in aqueous media under mild conditions is a preferred example. The selected PEG derivatives dramatically reduced aggregation and low shear viscosity of RBC resuspended in autologous plasma, and inhibited RBC agglutination by blood group-specific antibodies. The morphology and deformability of the PEG-treated cells were unaltered. PEG coating of the RBC surface is applicable to the treatment of a variety of diseases characterized by vaso-occlusion or impaired blood flow, e.g., myocardial infarction, shock, and sickle cell disease. An infusion solution is prepared containing red blood cells covalently bound to a PEG derivative having a molecular weight of between 2,000 and 5,000 Daltons and a PEG derivative having a molecular weight between 10,000 and 35,000 Daltons.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: November 6, 2001
    Inventors: Timothy C. Fisher, Jonathan K. Armstrong